Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, and Lipid metabolism and disorders.
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk
Bempedoic acid in the management of lipid disorders and cardiovascular risk. 2023 position paper of the International Lipid Expert Panel (ILEP)
The time is now: Achieving FH paediatric screening across Europe – The Prague Declaration
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force
Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)
EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
Safety of red yeast rice supplementation: A systematic review and meta-analysis of randomized controlled trials
The Role of Nutraceuticals in Statin Intolerant Patients
Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapy